Attached files
| file | filename |
|---|---|
| 10-Q - FORM 10-Q - Wave Life Sciences Ltd. | d25307d10q.htm |
| EX-32.1 - EX-32.1 - Wave Life Sciences Ltd. | d25307dex321.htm |
| EX-31.2 - EX-31.2 - Wave Life Sciences Ltd. | d25307dex312.htm |
| EX-31.1 - EX-31.1 - Wave Life Sciences Ltd. | d25307dex311.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the quarterly report of WAVE LIFE SCIENCES LTD. (the “Company”) on Form 10-Q for the period ended September 30, 2015, as filed with the Securities and Exchange Commission (the “Report”), I, Kyle Moran, Principal Financial and Accounting Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
| (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
December 17, 2015
| By: | /s/ Kyle Moran | |
| Kyle Moran | ||
| Vice President, Head of Finance (Principal | ||
| Financial Officer and Principal Accounting Officer) |